Administration Sequence- and Formulation-dependent Vaccination using Acid-degradable Polymeric Nanoparticles with High Antigen Encapsulation Capability

Yeon Su Choi,Jiin Felgner,Sharon Jan,Jenny Davies,D. Huw Davies,Young Jik Kwon
DOI: https://doi.org/10.1039/d3tb02834h
IF: 7.571
2024-06-02
Journal of Materials Chemistry B
Abstract:Vaccines aim to efficiently and specifically activate the immune system via a cascade of antigen uptake, processing, and presentation by antigen presenting cells (APCs) to CD4 and CD8 T cells, which in turn drive humoral and cellular immune responses. The specific formulation of the vaccine carriers can serve to not only shield the antigens from premature sequestering before reaching APCs but also favorably promote intracellular antigen presenting processing and presentation. This study compares two different acid-degradable polymeric nanoparticles that are capable of encapsulating moderately immunogenic antigen, GFP, at nearly full efficacy via electrostatic interactions or molecular affinity between His tag and Ni-NTA-conjugated monomers, resulting in GFP-encapsulating NPs composed of ketal monomers and crosslinkers (KMX/GFP NPs) and NTA-conjugated ketal monomers and crosslinkers (NKMX/GFP NPs), respectively. Encapsulated GFP was found to be released more rapidly from NKMX/GFP NPs (electrostatic encapsulation) than KMX/GFP NPs (affinity-driven encapsulation). In vivo vaccination studies demonstrated that while repeated injections of either NPs formulation resulted in poorer generation of anti-GFP antibodies than injections of the GFP antigen itself, sequential injections of NPs and GFP as a prime and booster vaccine, respectively, restored the humoral response. T cell recall assays indicated that NPs primarily assist APCs to antigen presentation T cells, and B cells need to be further stimulated by free protein antigens to produce antibodies. The findings of this study suggest that the immune response can be modulated by varying the chemistry of vaccine carriers and the sequences of vaccination with free antigens and antigen-encapsulating NPs.
materials science, biomaterials
What problem does this paper attempt to address?